# A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke

> **NCT07628933** · PHASE1 · NOT_YET_RECRUITING · sponsor: **BOE Technology Group Co., Ltd.** · enrollment: 35 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- AIS

## Interventions

- **DRUG:** Placebo of Human Umbilical Cord Mesenchymal Stromal Cells Injection
- **DRUG:** Human Umbilical Cord Mesenchymal Stem Cells Injection
- **DRUG:** Human Umbilical Cord Mesenchymal Stem Cells Injection

## Key facts

- **NCT ID:** NCT07628933
- **Lead sponsor:** BOE Technology Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2028-03-30
- **Final completion:** 2029-11-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628933, "A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07628933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*